Finding your next opportunity shouldn’t require piecing together multiple databases, alerts and research tools.
Fundz combines its own funding and M&A intelligence with hiring, leadership and other business signals into one connected view of each company, ranks opportunities against your ideal customer profile, and delivers the evidence and verified contacts to act on. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
NEONC TECHNOLOGIES HOLDINGS, INC.
The company shared information publicly (Regulation FD). An 8-K is the notice a US public company must file within four business days of a major event.
neonc.comAI Executive Summary
AI-powered analysis of 8-K filing content
NeOnc Technologies announced a scheduled End-of-Phase 1 Type B meeting with the FDA on November 17, 2026, regarding its product NEO212, representing a critical regulatory milestone in the drug development process.
Key Takeaways
FDA meeting scheduled for November 17, 2026, for End-of-Phase 1 Type B meeting on NEO212
This represents a significant regulatory milestone that could influence the company's development strategy and timeline
1 more takeaway
Related Filings (2)
2 more filings from NEONC TECHNOLOGIES HOLDINGS, INC. in the last 90 days
Filing Overview
What This Means
NEONC TECHNOLOGIES HOLDINGS, INC. filed with the SEC. Fundz turns 8-K material events into an alert with the right executive attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
4 screens from a live account. No signup.